Pfizer 2009 Annual Report Download - page 49

Download and view the complete annual report

Please find page 49 of the 2009 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 110

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110

Consolidated Balance Sheets
Pfizer Inc. and Subsidiary Companies
AS OF DECEMBER 31,
(MILLIONS, EXCEPT PREFERRED STOCK ISSUED AND PER COMMON SHARE DATA) 2009 2008
Assets
Cash and cash equivalents $ 1,978 $ 2,122
Short-term investments 23,991 21,609
Accounts receivable, less allowance for doubtful accounts: 2009—$176; 2008—$190 14,645 8,958
Short-term loans 1,195 824
Inventories 12,403 4,381
Current deferred tax assets and other current assets 6,962 5,034
Assets held for sale 496 148
Total current assets 61,670 43,076
Long-term investments and loans 13,122 11,478
Property, plant and equipment, less accumulated depreciation 22,780 13,287
Goodwill 42,376 21,464
Identifiable intangible assets, less accumulated amortization 68,015 17,721
Noncurrent deferred tax assets and other noncurrent assets 4,986 4,122
Total assets $212,949 $111,148
Liabilities and Shareholders’ Equity
Short-term borrowings, including current portion of long-term debt: 2009—$27; 2008—$937 $ 5,469 $ 9,320
Accounts payable 4,370 1,751
Dividends payable 1,454 2,159
Income taxes payable 10,107 656
Accrued compensation and related items 2,242 1,667
Current deferred tax liabilities and other current liabilities 13,583 11,456
Total current liabilities 37,225 27,009
Long-term debt 43,193 7,963
Pension benefit obligations 6,392 4,235
Postretirement benefit obligations 3,243 1,604
Noncurrent deferred tax liabilities 17,839 2,959
Other taxes payable 9,000 6,568
Other noncurrent liabilities 5,611 3,070
Total liabilities 122,503 53,408
Preferred stock, without par value, at stated value; 27 shares authorized; issued: 2009—1,511;
2008—1,804 61 73
Common stock, $0.05 par value; 12,000 shares authorized; issued: 2009—8,869;
2008—8,863 443 443
Additional paid-in capital 70,497 70,283
Employee benefit trusts (333) (425)
Treasury stock, shares at cost; 2009—799; 2008—2,117 (21,632) (57,391)
Retained earnings 40,426 49,142
Accumulated other comprehensive income/(expense) 552 (4,569)
Total Pfizer Inc. shareholders’ equity 90,014 57,556
Equity attributable to noncontrolling interests 432 184
Total shareholders’ equity 90,446 57,740
Total liabilities and shareholders’ equity $212,949 $111,148
See Notes to Consolidated Financial Statements, which are an integral part of these statements.
2009 Financial Report 47